# A Study in Patients With Myasthenia Gravis in China

> **NCT06700616** · — · ACTIVE_NOT_RECRUITING · sponsor: **AstraZeneca** · enrollment: 1199 (actual)

## Conditions studied

- Myasthenia Gravis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06700616
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-09-26
- **Primary completion:** 2027-12-30
- **Final completion:** 2027-12-30
- **Target enrollment:** 1199 (ACTUAL)
- **Last updated:** 2026-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06700616

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06700616, "A Study in Patients With Myasthenia Gravis in China". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06700616. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*